Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02599103
Other study ID # AS-IRB02-102083
Secondary ID
Status Completed
Phase N/A
First received September 15, 2015
Last updated November 5, 2015
Start date September 2013
Est. completion date September 2015

Study information

Verified date October 2015
Source Academia Sinica, Taiwan
Contact n/a
Is FDA regulated No
Health authority Academia Sinica:Taiwan
Study type Interventional

Clinical Trial Summary

Fats and oils play important roles in maintaining human nutrition and health through providing energy, essential fatty acids, and acting as modulators of many biological processes (signal transduction, immunity and inflammation). Due to differences in the fatty acid composition and content of antioxidants of individual cooking oils, the degree of oxidative and thermolytic reactions may vary oil by oil. It is lack of human feeding study to investigate the molecular mechanisms on how and which deep-fried oil exerts its adverse effects. The investigators are also lack of biomarkers for monitoring deep-fried oil exposure. Therefore, the purpose of this study is to compare how human body responds differently to several popular uncooked and deep-fried oils with varied fatty acid compositions with respect of oxylipin profile, inflammatory markers, non-targeted metabolomics, and transcriptomics. The investigators will recruit 20 volunteers, provided them once a week the milk shakes prepared from 60g of olive oil, soybean oil, palm oil, camellia oil, tallow (butter), and deep-fried oils of the last 4, respectively; in comparison with a no-fat milk shake control. The experiments lasted for 10 weeks.。Each time; serum, plasma, whole blood and urine samples were collected at baseline, after 2 hours, and after 4 hours. The investigators anticipate to find biomarker(s) for deep-frying, and contribute to the understanding of molecular mechanisms on how deep-fried oils exert adverse effects toward health through integrative omics or so-called system biology approaches.


Recruitment information / eligibility

Status Completed
Enrollment 17
Est. completion date September 2015
Est. primary completion date September 2015
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Male
Age group 20 Years to 50 Years
Eligibility Inclusion Criteria:

- Non-smoking, non-drinker, usual dietary intake

- BMI : 18.5~27 kg/m2

Exclusion Criteria:

1. Over the past two weeks have suffered from acute illness.

2. None of the subjects was taking any supplemental vitamins, antioxidants or medication at that time.

3. Taking steroids or non-steroidal anti-inflammatory drug, such as Aspirin or Panadol in the past one week.

4. Cancer or other severe diseases was diagnosed.

Study Design

Allocation: Non-Randomized, Endpoint Classification: Safety Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Caregiver), Primary Purpose: Basic Science


Related Conditions & MeSH terms


Intervention

Other:
Fat-free milkshake
participants drinks a fat-free milk shakes
Olive oil
participants drinks the milk shakes prepared from 60g of olive oil
Soybean oil
participants drinks the milk shakes prepared from 60g of soybean oil
Fried soybean oil
participants drinks the milk shakes prepared from 60g of fried soybean oil
Palm oil
participants drinks the milk shakes prepared from 60g of palm oil
Fried palm oil
participants drinks the milk shakes prepared from 60g of fried palm oil
Camellia oil
participants drinks the milk shakes prepared from 60g of camellia oil
Fried camellia oil
participants drinks the milk shakes prepared from 60g of fried camellia oil
Tallow
participants drinks the milk shakes prepared from 60g of tallow
Fried tallow
participants drinks the milk shakes prepared from 60g of fried tallow

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Academia Sinica, Taiwan

Outcome

Type Measure Description Time frame Safety issue
Primary The changs of metabolomics profile between before and after oil consumption This is a metabolomics study. We measured retention time (min), mass and abundance of serum metabolites with LC-QTOF at 3 time points. Then, we compared the abundance of metabolites between different oil consumption time ( before and after ) and assessed the health effects of cooking oils. baseline to 2 hours and 4 hours after oil consumption No
See also
  Status Clinical Trial Phase
Recruiting NCT04552093 - Hepatic Arterial Infusion Pump Chemotherapy Combined With Systemic Chemotherapy (PUMP-IT) Phase 2/Phase 3
Completed NCT04192565 - A Prospective Investigation of the ColubrisMX ELS System N/A
Completed NCT05178745 - A Prospective Observational Cohort Study Evaluating Resection Rate in Patients With Metastatic Colorectal Cancer Treated With Aflibercept in Combination With FOLFIRI - Observatoire résection
Recruiting NCT03561350 - Detect Microsatellite Instability Status in Blood Sample of Advanced Colorectal Cancer Patients by Next-Generation Sequencing
Recruiting NCT06128798 - Effect of Preoperative Immunonutrition Versus Standard Oral Nutrition in Patient Undergoing Colorectal Surgery. N/A
Recruiting NCT03602677 - Indocyanine Green Fluorescence Imaging in Prevention of Colorectal Anastomotic Leakage N/A
Completed NCT03631407 - Safety and Efficacy of Vicriviroc (MK-7690) in Combination With Pembrolizumab (MK-3475) in Participants With Advanced/Metastatic Microsatellite Stable (MSS) Colorectal Cancer (CRC) (MK-7690-046) Phase 2
Withdrawn NCT04192929 - Chromoendoscopy or Narrow Band Imaging (NBI) for Improving Adenoma Detection in Colonoscopy N/A
Recruiting NCT03042091 - Neomycin and Metronidazole Hydrochloride With or Without Polyethylene Glycol in Reducing Infection in Patients Undergoing Elective Colorectal Surgery Early Phase 1
Completed NCT02889679 - Underwater Resection of Non-pedunculated Colorectal Lesions N/A
Terminated NCT02842580 - De-escalation Chemotherapies Versus Escalation in Non Pre-treated Unresectable Patients With Metastatic Colorectal Cancer Phase 2
Completed NCT02564835 - Effects of Yoga on Cognitive and Immune Function in Colorectal Cancer N/A
Completed NCT02149108 - Nintedanib (BIBF 1120) vs Placebo in Refractory Metastatic Colorectal Cancer (LUME-Colon 1) Phase 3
Completed NCT02503696 - Sample Collection Study to Evaluate DNA Markers in Subjects With Inflammatory Bowel Disease (IBD) N/A
Completed NCT01719926 - Phase I Platinum Based Chemotherapy Plus Indomethacin Phase 1
Completed NCT01669109 - Hatha Yoga for Patients With Colorectal Cancer N/A
Recruiting NCT01428752 - Study of Prevalence of Colorectal Adenoma in 30- to 49-year-old Subjects With a Family History of Colorectal Cancer N/A
Completed NCT01978717 - General Anesthesia Combined With Epidural Anesthesia Mitigates the Surgical Stress-related Immunosuppression in Patients With Colorectal Cancer N/A
Completed NCT01877018 - Colorectal Cancer Screening in Primary Care N/A
Completed NCT00947206 - Lay Health Workers and Colorectal Cancer Screening Among Chinese Americans N/A